Link Pharma Chem sets Aug 20 date for 41st AGM

3 min read     Updated on 27 Jul 2026, 04:07 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Link Pharma Chem Limited convenes its 41st AGM on August 20, 2026, via video conference. Key agenda items include adopting FY26 financials, appointing Y. S. Thakar & Co. as cost auditors, and Vijay Bhatt & Co. as secretarial auditors. Shareholders will also vote on the re-appointment of Satish G. Thakur and Rishikesh Thakur to their respective executive roles for three-year terms.

powered bylight_fuzz_icon
46694258

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem Limited has scheduled its 41st Annual General Meeting (AGM) for Thursday, August 20, 2026, at 11:30 a.m. IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in compliance with Ministry of Corporate Affairs circulars. This virtual format allows shareholders to participate remotely, ensuring broader accessibility while adhering to regulatory guidelines regarding physical attendance restrictions.

The primary objective of the gathering is to transact ordinary business, including the consideration and adoption of the Audited Financial Statements for the financial year ended March 31, 2026. Additionally, shareholders will vote on the re-appointment of Mr. Satish Thakur as a director, who retires by rotation and offers himself for re-election. The Board of Directors has recommended these actions based on the company’s performance and governance requirements for FY26.

Special business items form a significant portion of the agenda, focusing on key managerial and audit appointments. Shareholders are asked to approve the ratification of remuneration for Cost Auditors M/s. Y. S. Thakar & Co., who have been appointed by the Board to audit cost records for FY27. The proposed remuneration is ₹45,000 per annum plus applicable taxes and reimbursement of actual out-of-pocket expenses incurred during the audit process.

Furthermore, the meeting seeks approval for the appointment of Vijay Bhatt & Co., Practicing Company Secretaries, as Secretarial Auditors for a four-year term from FY27 to FY30. This appointment aligns with Section 204 of the Companies Act, 2013, and Regulation 24A of the SEBI Listing Regulations. The firm’s remuneration will be mutually agreed upon by the Board and the auditors, with provisions for revision based on inflation during the tenure.

The most critical special resolutions involve the re-appointment of senior leadership. Shareholders must pass a special resolution to re-appoint Mr. Satish G. Thakur as Chairman & Whole-time Director for three years, effective June 24, 2026, with a consolidated salary of ₹4.00 Lacs per month. Similarly, Mr. Rishikesh Thakur is up for re-appointment as Managing Director for three years, effective September 24, 2026, at a consolidated salary of ₹3.00 Lacs per month. Both directors have extensive experience in the chemical industry, with Mr. Thakur bringing over 43 years of expertise and Mr. Rishikesh Thakur contributing over 15 years in operations and R&D.

Key Dates and Voting Details

Event Date/Period
E-Voting Period August 17–19, 2026
Record Date August 13, 2026
Book Closure August 14–20, 2026
AGM Date August 20, 2026

Shareholders holding shares as on the cut-off date of August 13, 2026, are eligible to vote. Remote e-voting begins on Monday, August 17, 2026, at 9:00 a.m. and ends on Wednesday, August 19, 2026, at 5:00 p.m. The Register of Members and Share Transfer Books will remain closed from Friday, August 14, 2026, to Thursday, August 20, 2026, inclusive. Participants can join the VC/OAVM session via InstaMeet, with login facilities opening 30 minutes prior to the scheduled start time.

Leadership and Audit Appointments

Resolution Candidate/Firm Tenure/Details
Cost Auditor Y. S. Thakar & Co. FY27; ₹45,000 p.a. + taxes
Secretarial Auditor Vijay Bhatt & Co. 4 years (FY27–FY30)
Chairman & WTD Satish G. Thakur 3 years; ₹4.00 Lacs/month
Managing Director Rishikesh Thakur 3 years; ₹3.00 Lacs/month

The Board emphasizes that none of the directors or key managerial personnel have any financial interest in the auditor appointments, except through their shareholdings. For the leadership re-appointments, conflicts are limited to the inter-se relationship between Mr. Satish G. Thakur and Mr. Rishikesh Thakur, who are related, and their respective shareholding interests in the company.

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-1.48%-1.48%-13.64%-23.45%-29.35%

How might the re-appointment of long-serving leadership impact Link Pharma Chem's strategic direction and innovation pipeline in the competitive chemical sector?

What are the implications of the fixed remuneration structure for the Chairman and Managing Director compared to industry benchmarks for similar roles?

Could the appointment of a new Secretarial Auditor for a four-year term signal upcoming changes in corporate governance practices or compliance strategies?

Link Pharma Chem re-appoints Satish Thakur as Chairman

1 min read     Updated on 24 May 2026, 11:00 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Link Pharma Chem Limited will re-appoint Mr. Satish G. Thakur as Chairman and Whole-time Director for a three-year term effective June 24, 2026, pending shareholder approval. Mr. Thakur, the father of the Managing Director, has over 43 years of experience and has been with the company since its inception.

powered bylight_fuzz_icon
41146199

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem Limited has announced the re-appointment of Mr. Satish G. Thakur as Chairman and Whole-time Director of the company. The decision is subject to the approval of shareholders at the ensuing Annual General Meeting. The disclosure was made in compliance with SEBI regulations.

Mr. Thakur is scheduled to assume office on June 24, 2026. His tenure will extend for a period of three years from the date of appointment. He has been associated with link pharma chem since its incorporation and holds a B.Sc. and L.Tech degree.

The director brings extensive experience to the role, with over 43 years in the industry. His expertise includes project design and development. He has been involved in the operations of the company since its inception.

Key Appointment Details

Sr. No. Disclosure Requirement Details
01. Reason for change Re-appointment of Mr. Satish G Thakur (DIN: 00292129) as Chairman and Whole-time Director.
02. Date of appointment & term June 24, 2026, for a period of 3 years subject to shareholder approval.
03. Brief profile Associated with the company since incorporation; holds B.Sc., L.Tech; over 43 years of experience.
04. Relationship Father of Mr. Rishikesh Thakur, Managing Director.

The company's registered office is located at Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat).

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-1.48%-1.48%-13.64%-23.45%-29.35%

How might the dual family leadership structure, with Mr. Satish Thakur as Chairman and his son Mr. Rishikesh Thakur as Managing Director, influence corporate governance practices and minority shareholder confidence at Link Pharma Chem?

What strategic initiatives or expansion plans could Mr. Thakur prioritize during his 2026-2029 tenure given the evolving competitive landscape in the Indian pharmaceutical chemicals sector?

How are institutional investors and proxy advisory firms likely to respond to the shareholder vote on this re-appointment, particularly given increasing scrutiny of family-controlled pharma companies in India?

More News on Link Pharma Chem

1 Year Returns:-23.45%